BioLine Rx Ltd (BLRX) Stock Price, Quote, News & History

BLRXNASDAQ
$2.55
-0.04-1.54%
At close: Sep 8, 5:00 PM EST
$2.22
-0.37-14.29%
Pre-Market: 8:59 AM EST

BioLine Rx (BLRX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.80M
Investing Cash Flow (TTM)
12.39M
Financing Cash Flow (TTM)
-4.49M
Free Cash Flow (TTM)
-10.83M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.90M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.41M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
8.09
PB Ratio (TTM)
0.90
Earnings Yield % (TTM)
0.00%
Earnings Yield % (FWD)
-49.07%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.84

Company Debt

Total Debt
$6.70M
LT Debt
$2.22M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$374.00K
Total Cash
$4.63M
Debt to Equity
0.58
Issuance of Debt (TTM)
-$374.00K
Repayment of Debt (TTM)
-$4.87M

Key Statistics

Open
-
Close
$2.55
Volume / Avg.
220.00 / 20.30K
Day Range
- - -
52 Wk Range
2.15 - 4.56
Market Cap
$10.76M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
2.78%
Days to Cover
19.81

About

Sector
Health Care
Industry
Biotechnology
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for th...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioLine Rx (BLRX) stock?

A

You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for BioLine Rx (BLRX) stock?

A

BioLine Rx has a consensus price target of $19.00.

Q

What is the current price for BioLine Rx (BLRX)?

A

The stock price for BioLine Rx (NASDAQ: BLRX) is $2.22 last updated September 9, 2026 at 4:34 PM EDT.

Q

Does BioLine Rx (BLRX) pay a dividend?

A

There are no upcoming dividends for BioLine Rx.

Q

When is BioLine Rx (NASDAQ:BLRX) reporting earnings?

A

BioLine Rx does not have any upcoming earnings scheduled.

Q

Is BioLine Rx (BLRX) going to split?

A

There is no upcoming split for BioLine Rx.

Q

What sector and industry does BioLine Rx (BLRX) operate in?

A

BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.